Everpure, Inc (P)

Everpure (P) trades at a very high P/E of 178.44 and Forward P/E of 31.22—suggesting the market currently prices in either a large near-term earnings normalization/beat potential (forward multiple looks dramatically lower) or that trailing earnings are unusually depressed versus expected earnings.

The PEG is 0.80, which (despite the extreme trailing P/E) can indicate valuation is not wildly out of line with expected growth, assuming the growth inputs are credible and sustained.

Price-to-sales is elevated at P/S 10.22 and P/B 28.29—both imply the business earns relatively strong returns on a small equity base, or that equity is compressed while investors pay up for earnings power.

Cash-flow valuation is rich: P/FCF 340.01 and EV/EBITDA 111.10, pointing to expensive current cash flow/EBITDA relative to enterprise value.

Overall: on traditional value metrics (P/E trailing, P/FCF, EV/EBITDA, P/B), the stock looks expensive. However, the forward P/E and PEG together hint the market expects a significant improvement in earnings quality/level.

Profitability is strong on margins: Gross Margin 79.94%, Operating Margin 27.21%, and Net/Profit Margin 53.84% (very high; profit margin especially stands out—confirming accounting/one-off effects is important, but the snapshot suggests exceptional profitability).

Return metrics are robust: ROA 10.04%, ROE 111.10%, and ROIC 34.55%. Extremely high ROE is often amplified by buybacks, leverage, or a small equity denominator.

Earnings quality signals: EPS (ttm) is 0.15 with EPS this Y 0.11 and EPS next Y 1.39—this implies a very large step-up expected in normalized earnings next year.

Quarterly growth also looks strong: EPS Q/Q 50.82% and Sales Q/Q 38.96%.

Net takeaway: if earnings ramp to the next-Y expectation, the multiple compression could be justified; if not, the trailing valuation (and especially P/FCF/EV/EBITDA) leaves little margin of safety.

Guidance/forecast growth looks steep: EPS next Y 1.39 versus EPS this Y 0.11 (very large expected acceleration).

Past growth trends are mixed but constructive: EPS past 3Y/5Y is shown as 69.73% (as provided), and the EPS Y/Y TTM is 27.21% while Sales Y/Y TTM is 53.84%, indicating revenue momentum is stronger than trailing EPS momentum.

Relative forward growth is supported by PEG = 0.80, which typically indicates growth may be priced reasonably vs growth rates (again, only as reliable as the growth estimates).

Caution for growth investors: because the forward earnings step-up is so large, the stock can be sensitive to execution, industry demand, pricing, and any accounting normalization.

Liquidity appears solid: Quick Ratio 1.44 and Current Ratio 1.39 suggest the company can cover near-term obligations without relying heavily on inventory.

Leverage is low on a book basis: Debt/Eq 0.73 and LT Debt/Eq 0.73 indicate no obvious debt-driven stress in this snapshot.

Profitability with manageable leverage is generally positive, but the valuation is still the main issue (expensive multiples) rather than balance-sheet fragility.

Conclusion: financial health looks adequate-to-strong on liquidity and leverage, which supports survivability if earnings normalize.

Insider ownership is 0.73 (unit not specified, but as provided it indicates meaningful insider alignment rather than purely passive management).

Insider transactions show Insider Trans = 4.97% (as provided). Without direction (buy/sell), treat this as activity rather than a definitive signal.

Institutional ownership is 0.25 (as provided) with Inst Trans = 5.48%, suggesting institutions participate and are actively adjusting positions.

Interpretation: ownership signals look mixed but not absent; for a high-multiple stock, monitoring whether institutions keep increasing exposure during earnings inflection matters.

The stock’s price is 130.78 versus prior close 130.05, +0.56% today—neutral intraday.

52-week range is wide: 52W High 147.26, 52W Low 130.05. Price is near the upper end of the provided 52W low-high band, suggesting investors have been paying up recently.

Relative to key valuation expectations, the stock is currently positioned for further progress; this increases downside risk if growth/earnings surprises disappoint.

Technical context (moving averages): SMA20 132.43, SMA50 130.78, SMA200 130.05. Price is slightly below/around short-term levels but above the longer-term anchor, consistent with a stable-to-up trend.

Overall performance metrics (as provided) show very strong multi-year returns (e.g., Perf 3Y 121.51%, Perf 5Y 267.15%). That aligns with a “growth story,” but it also implies expectations may already be elevated.

Volatility is low-to-moderate in the dataset: Volatility 1.56% with ATR(14) 6.83. That suggests daily swings may be manageable, though the high valuation can still amplify drawdowns during disappointments.

Momentum indicators: RSI (14) = 56.78 implies neutral-to-slightly bullish momentum (not deeply overbought).

Beta 0.73 suggests lower market sensitivity than the S&P 500 in the data snapshot.

Relative volume is 1.41 with volume 6.83M (and Avg Volume 6.43M). This can indicate mild interest on the move, not a blow-off.

Takeaway: momentum is not extremely overheated by RSI; valuation risk remains the dominant factor.